Resultados: 115

    Latent TB infection: updated and consolidated guidelines for programmatic management

    Background The programmatic management of latent tuberculosis infection (LTBI) in populations most at risk of developing TB remains a critical activity to disrupt Mycobacterium tuberculosis transmission, as identified in the End TB Strategy. LTBI is defined as a state of persistent immune response to sti...

    Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV

    Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or ...

    Guidelines on the public health response to pretreatment HIV drug resistance

    This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) among people without prior antiretroviral (ARV) drug exposure or people with prior ARV exposure who are initiating or reinitiating first...

    Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

    The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV. The first set of recommendation...

    Guidelines for treatment of drug-susceptible tuberculosis and patient care: 2017 update

    The present guideline update aims to use the best available evidence on the treatment of drug-susceptible TB, as well as on interventions to ensure adequate patient care and support, in order to inform policy decisions made in these technical areas by national TB control programme managers, national poli...

    WHO guidelines on use of medically important antimicrobials in food-producing animals

    These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve the ...

    Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups

    This guideline provides global, evidence-informed recommendations on preventive chemotherapy (deworming), as a public health intervention in areas endemic for soil-transmitted helminths, to decrease the worm burden of soil-transmitted helminth infections in children, adolescent girls, women of reproducti...

    WHO guideline: fortification of maize flour and corn meal with vitamins and minerals

    Industrial fortification of maize flour and corn meal with at least iron has been practiced for many years in several countries in the Americas and Africa, where these ingredients are used in the preparation of many common national dishes. This guideline provides global, evidence-informed recommendations...

    Guidelines on HIV self-testing and partner notification: supplement to consolidated guidelines on HIV testing services

    Since the release of the consolidated guidelines in 2015, new evidence has emerged. Consequently, in an effort to further support countries, programme managers, health workers and other stakeholders seeking to achieve national and international HIV goals, this 2016 update issues new recommendations and a...

    WHO guidelines on hepatitis B and C testing

    Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive th...